Thomas Prébet Selected Research

FAM protocol

1/2004

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Prébet Research Topics

Disease

8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 01/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 03/2006
3	Neoplasms (Cancer) 01/2018 - 08/2011
2	Leukemia 01/2018 - 11/2012
1	Multiple Myeloma 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Lymphoma (Lymphomas) 12/2016
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 12/2016
1	Anemia 01/2016
1	Pathologic Complete Response 05/2008
1	Hematologic Neoplasms (Hematological Malignancy) 05/2008
1	Leukopenia 01/2004
1	Neutropenia 01/2004
1	Thrombocytopenia (Thrombopenia) 01/2004

Drug/Important Bio-Agent (IBA)

3	Azacitidine (5 Azacytidine)FDA Link 01/2016 - 08/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2012 - 01/2004
1	Immunomodulating AgentsIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2012
1	AnthracyclinesIBA 11/2012
1	Messenger RNA (mRNA)IBA 04/2012
1	EnzymesIBA 08/2011
1	Histone MethyltransferasesIBA 08/2011
1	Histones (Histone)IBA 08/2011
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004
1	NucleotidesIBA 01/2004
1	Arabinofuranosylcytosine TriphosphateIBA 01/2004
1	fludarabineIBA 01/2004

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 12/2016 - 01/2004
3	Therapeutics 12/2016 - 08/2011
2	Stem Cell Transplantation 03/2006 - 01/2004
1	Aftercare (After-Treatment) 12/2016
1	Induction Chemotherapy 11/2012
1	Hematopoietic Stem Cell Transplantation 05/2008
1	Transplantation 05/2008
1	FAM protocol 01/2004
1	Combination Drug Therapy (Combination Chemotherapy) 01/2004